NDC 17856-2133

POSACONAZOLE

Posaconazole

POSACONAZOLE is a Oral Tablet, Delayed Release in the Human Prescription Drug category. It is labeled and distributed by Atlantic Biologicals Corp.. The primary component is Posaconazole.

Product ID17856-2133_6a517229-60aa-44f2-9d66-e1c90a9cf244
NDC17856-2133
Product TypeHuman Prescription Drug
Proprietary NamePOSACONAZOLE
Generic NamePosaconazole
Dosage FormTablet, Delayed Release
Route of AdministrationORAL
Marketing Start Date2019-08-28
Marketing CategoryANDA /
Application NumberANDA212411
Labeler NameATLANTIC BIOLOGICALS CORP.
Substance NamePOSACONAZOLE
Active Ingredient Strength100 mg/1
Pharm ClassesAzole Antifungal [EPC], Azoles [CS]
NDC Exclude FlagN
Listing Certified Through2023-12-31

Packaging

NDC 17856-2133-1

100 POUCH in 1 BOX, UNIT-DOSE (17856-2133-1) > 1 TABLET, DELAYED RELEASE in 1 POUCH (17856-2133-2)
Marketing Start Date2022-03-07
NDC Exclude FlagN
Sample Package?N

Drug Details

NDC Crossover Matching brand name "POSACONAZOLE" or generic name "Posaconazole"

NDCBrand NameGeneric Name
0254-2045POSACONAZOLEposaconazole
0406-7711POSACONAZOLEposaconazole
0527-2133POSACONAZOLEPosaconazole
60687-523PosaconazolePosaconazole
70748-258POSACONAZOLEPOSACONAZOLE
0085-1328NOXAFILposaconazole
0085-2224NOXAFILposaconazole
0085-4324NOXAFILposaconazole
0085-4331NOXAFILposaconazole

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.